the Bispecific PSMAxCD3 Antibody CC-1 in Patients With Castration Resistant Prostate Carcinoma (clinicaltrials.gov) - Apr 24, 2020 - P1; N=86; Recruiting; Sponsor: University Hospital Tuebingen; Trial primary completion date: Mar 2020 ➔ Mar 2022
Clinical • Trial primary completion date • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor • Urothelial Cancer
|